This show, called, “Between the Vineyards and the Fields,” which runs until July 30, is the follow-up to their show last July at the Artspace Gallery run by the Tel Aviv Municipality.

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

To find out, the scientists turned to surface plasmon resonance, a technique that quantifies molecular interactions in real time. It showed that ApoE3Ch clings onto tau monomers immobilized on sensor ...

The week after seeing its partner Roche cut and run, UCB has reported the failure of its anti-tau antibody bepranemab to improve cognition and function in people with early Alzheimer’s disease.

Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s disease drug candidate on the cusp of the release of phase 2a data ...

New therapy that targets and destroys tau tangles is a promising future Alzheimer's disease treatment Date: September 20, 2024 Source: UK Research and Innovation Summary: Scientists have developed ...

Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.

Mel Taing Tau Lewis’s first-ever museum survey, just opened at the ICA, is called “Spirit Level,” though there’s much to hold your gaze right here on earth.

One dose of a new treatment, delivered by nasal spray, clears away build-ups of the toxic tau protein associated with Alzheimer’s disease from inside brain cells, improving memory, according to ...

The T'au command unit, the Ethereal, can also pilot a battlesuit, whether the heavy-armor Enforcer or the more agile Coldstar.

Learn how tau protein may influence the development of Alzheimer's disease and what you can do to manage it.